1. Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Inn Med. 1923; 6:93–100.
2. Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med. 1960; 263:51–8.
Article
3. Yang H, Peng L, Jian M, Qin L. Clinical analysis of 15 patients with relapsing auricular polychondritis. Eur Arch Otorhinolaryngol. 2014; 271:473–6.
Article
4. Yeo SW, Kim HR, Yoon CH, Park SN. A case of relapsing polychondritis with inner ear symptom improved by plasmaphresis. Korean Journal of Otorhinolaryngology-Head and Neck Surgery. 2005; 48:1290–3.
5. de Barros AP, Nakamura NA, Santana Tde F, Motta JQ, Bianchi WA. Infliximab in relapsing polychondritis. Rev Bras Reumatol. 2010; 50:211–6.
6. Abdwani R, Kolethekkat AA, Al Abri R. Refractory relapsing polychondritis in a child treated with antiCD20 monoclonal antibody (rituximab): first case report. Int J Pediatr Otorhinolaryngol. 2012; 76:1061–4.
Article
7. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976; 55:193–215.
8. Damiani JM, Levine HL. Relapsing polychondritis–report of ten cases. Laryngoscope. 1979; 89:929–46.
9. Martin J, Roenigk HH, Lynch W, Tingwald FR. Relapsing polychondritis treated with dapsone. Arch Dermatol. 1976; 112:1272–4.
Article
10. Park J, Gowin KM, Schumacher HR Jr. Steroid sparing effect of methotrexate in relapsing polychondritis. J Rheumatol. 1996; 23:937–8.